Upstream Bio Stock Performance
| UPB Stock | 27.15 0.17 0.62% |
On a scale of 0 to 100, Upstream Bio holds a performance score of 12. The entity has a beta of 0.83, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Upstream Bio's returns are expected to increase less than the market. However, during the bear market, the loss of holding Upstream Bio is expected to be smaller as well. Please check Upstream Bio's skewness, and the relationship between the potential upside and rate of daily change , to make a quick decision on whether Upstream Bio's existing price patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Upstream Bio are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, Upstream Bio sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (0.62) | Five Day Return (9.83) | Ten Year Return 23.41 | All Time Return 23.41 |
1 | Can Upstream Bio Inc. stock resist sector downturns - Portfolio Value Summary Expert Approved Momentum Ideas - newser.com | 10/24/2025 |
2 | How strong is Upstream Bio Inc. stock revenue growth - Stop Loss Expert Verified Movement Alerts - newser.com | 11/07/2025 |
3 | Is Upstream Bio Rethinking Its Growth Priorities Amid Mounting Losses and Shelf Registration | 11/11/2025 |
4 | What risks investors should watch in Upstream Bio Inc. stock - 2025 Volatility Report Growth-Oriented Investment Plans - newser.com | 11/19/2025 |
5 | Critical Review Upstream Bio Its Peers | 12/11/2025 |
6 | Mizuho initiates Upstream Bio stock with Outperform rating on asthma drug potential - Investing.com | 12/17/2025 |
7 | Upstream Bio Shares Down 3.4 percent - Time to Sell - MarketBeat | 12/30/2025 |
| Begin Period Cash Flow | 25.8 M | |
| Total Cashflows From Investing Activities | -59.5 M |
Upstream Bio Relative Risk vs. Return Landscape
If you would invest 1,897 in Upstream Bio on October 4, 2025 and sell it today you would earn a total of 818.00 from holding Upstream Bio or generate 43.12% return on investment over 90 days. Upstream Bio is generating 0.6602% of daily returns assuming volatility of 4.2704% on return distribution over 90 days investment horizon. In other words, 38% of stocks are less volatile than Upstream, and above 87% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Upstream Bio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Upstream Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Upstream Bio, and traders can use it to determine the average amount a Upstream Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1546
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | UPB | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Upstream Bio is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Upstream Bio by adding it to a well-diversified portfolio.
Upstream Bio Fundamentals Growth
Upstream Stock prices reflect investors' perceptions of the future prospects and financial health of Upstream Bio, and Upstream Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Upstream Stock performance.
| Return On Equity | -0.41 | ||||
| Return On Asset | -0.28 | ||||
| Operating Margin | (55.39) % | ||||
| Current Valuation | 1.1 B | ||||
| Shares Outstanding | 54.04 M | ||||
| Price To Book | 3.88 X | ||||
| Price To Sales | 524.17 X | ||||
| Revenue | 2.37 M | ||||
| Gross Profit | 2.8 M | ||||
| EBITDA | (77.67 M) | ||||
| Net Income | (62.81 M) | ||||
| Total Debt | 1.83 M | ||||
| Book Value Per Share | 7.01 X | ||||
| Cash Flow From Operations | (59.17 M) | ||||
| Earnings Per Share | (6.40) X | ||||
| Market Capitalization | 1.26 B | ||||
| Total Asset | 481.72 M | ||||
| Retained Earnings | (190.78 M) | ||||
| Working Capital | 468.42 M | ||||
About Upstream Bio Performance
By analyzing Upstream Bio's fundamental ratios, stakeholders can gain valuable insights into Upstream Bio's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Upstream Bio has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Upstream Bio has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.13) | (0.12) | |
| Return On Capital Employed | (0.15) | (0.16) | |
| Return On Assets | (0.13) | (0.12) | |
| Return On Equity | (0.13) | (0.15) |
Things to note about Upstream Bio performance evaluation
Checking the ongoing alerts about Upstream Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Upstream Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Upstream Bio appears to be risky and price may revert if volatility continues | |
| Upstream Bio has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the last year's revenue of 2.37 M. Reported Net Loss for the year was (62.81 M) with profit before taxes, overhead, and interest of 2.8 M. | |
| Upstream Bio generates negative cash flow from operations | |
| Over 93.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from news.google.com: Upstream Bio Shares Down 3.4 percent - Time to Sell - MarketBeat |
- Analyzing Upstream Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Upstream Bio's stock is overvalued or undervalued compared to its peers.
- Examining Upstream Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Upstream Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Upstream Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Upstream Bio's stock. These opinions can provide insight into Upstream Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Upstream Stock analysis
When running Upstream Bio's price analysis, check to measure Upstream Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Upstream Bio is operating at the current time. Most of Upstream Bio's value examination focuses on studying past and present price action to predict the probability of Upstream Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Upstream Bio's price. Additionally, you may evaluate how the addition of Upstream Bio to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |